Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Donor COVID-19 Infection Status on the Recipient in Allogeneic Hematopoietic Stem Cell Transplantation.

NCT05675826 is registered in ClinicalTrials.gov with Chen Suning as lead sponsor.

NCT NCT05675826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05675826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Donor COVID-19 Infection Status on the Recipient in Allogeneic Hematopoietic Stem Cell Transplantation.
Lead sponsor
Chen Suning
Phase
Observational
Overall status
Unknown status
Start date
December 26, 2022
Completion date
April 30, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, hematopoietic stem cell transplantation